CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nesbit, C. E.
Right arrow Articles by Prochownik, E. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nesbit, C. E.
Right arrow Articles by Prochownik, E. V.

Cell Growth & Differentiation, Vol 9, Issue 9 731-741, Copyright © 1998 by American Association of Cancer Research


ARTICLES

Differential apoptotic behaviors of c-myc, N-myc, and L-myc oncoproteins

CE Nesbit, LE Grove, X Yin and EV Prochownik
Department of Pediatrics, Children's Hospital of Pittsburgh, Pennsylvania 15213, USA.

c-, N-, and L-myc are related nuclear oncoproteins that bind similar DNA sites and cooperate with activated ras oncogenes to transform primary fibroblasts. Although c-myc can also promote apoptosis in some cells after growth factor withdrawal or exposure to cytotoxic agents, roles for N- and L-myc in apoptosis remain undetermined. To address this, c-, N-, or L-myc were stably expressed in the interleukin 3 (IL-3)-dependent 32D hematopoietic cell line. The apoptotic response of each cell line was assessed after IL-3 withdrawal or treatment with four structurally unrelated cytotoxic agents. All three oncoproteins accelerated apoptosis after IL-3 withdrawal. In contrast, whereas c-myc overexpression generally sensitized cells to cytotoxic drugs, N-myc and L-myc overexpression produced resistance. myc expression tended to be associated with a more robust G2-M arrest after drug exposure, but this did not correlate with drug sensitivity or resistance. Bcl-2 and Bcl-X(L) protected control cells against apoptosis after either IL-3 withdrawal or drug exposure, although in some cases this effect could be overridden by myc oncoproteins, particularly N-myc and L-myc. Our results suggest that the apoptotic pathways activated upon IL-3 withdrawal and cytotoxic drug treatment are distinct and differentially affected by members of the myc and Bcl-2 families.


This article has been cited by other articles:


Home page
Genes Dev.Home page
F. J. Swartling, M. R. Grimmer, C. S. Hackett, P. A. Northcott, Q. W. Fan, D. D. Goldenberg, J. Lau, S. Masic, K. Nguyen, S. Yakovenko, et al.
Pleiotropic role for MYCN in medulloblastoma
Genes & Dev., May 15, 2010; 24(10): 1059 - 1072.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Gostissa, S. Ranganath, J. M. Bianco, and F. W. Alt
Chromosomal location targets different MYC family gene members for oncogenic translocations
PNAS, February 17, 2009; 106(7): 2265 - 2270.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Hachem and R. B. Gartenhaus
Oncogenes as molecular targets in lymphoma
Blood, September 15, 2005; 106(6): 1911 - 1923.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
W. R. Atchley and A. D. Fernandes
Sequence signatures and the probabilistic identification of proteins in the Myc-Max-Mad network
PNAS, May 3, 2005; 102(18): 6401 - 6406.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Yi, R. Jaffe, and E. V. Prochownik
The CCL6 Chemokine Is Differentially Regulated by c-Myc and L-Myc, and Promotes Tumorigenesis and Metastasis
Cancer Res., June 1, 2003; 63(11): 2923 - 2932.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
A. Biroccio, B. Benassi, G. Filomeni, S. Amodei, S. Marchini, G. Chiorino, G. Rotilio, G. Zupi, and M. R. Ciriolo
Glutathione Influences c-Myc-induced Apoptosis in M14 Human Melanoma Cells
J. Biol. Chem., November 15, 2002; 277(46): 43763 - 43770.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
Z. M. Mu, X. Y. Yin, and E. V. Prochownik
Pag, a Putative Tumor Suppressor, Interacts with the Myc Box II Domain of c-Myc and Selectively Alters Its Biological Function and Target Gene Expression
J. Biol. Chem., November 8, 2002; 277(45): 43175 - 43184.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
X. Yin, L. Grove, K. Rogulski, and E. V. Prochownik
Myc Target in Myeloid Cells-1, a Novel c-Myc Target, Recapitulates Multiple c-Myc Phenotypes
J. Biol. Chem., May 31, 2002; 277(22): 19998 - 20010.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X.-Y. Yin, L. Grove, N. S. Datta, K. Katula, M. W. Long, and E. V. Prochownik
Inverse Regulation of Cyclin B1 by c-Myc and p53 and Induction of Tetraploidy by Cyclin B1 Overexpression
Cancer Res., September 1, 2001; 61(17): 6487 - 6493.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Biroccio, B. Benassi, S. Amodei, C. Gabellini, D. Del Bufalo, and G. Zupi
C-Myc Down-Regulation Increases Susceptibility to Cisplatin through Reactive Oxygen Species-Mediated Apoptosis in M14 Human Melanoma Cells
Mol. Pharmacol., July 1, 2001; 60(1): 174 - 182.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Primdahl, H. von der Maase, M. Christensen, H. Wolf, and T. F. Orntoft
Allelic Deletions of Cell Growth Regulators during Progression of Bladder Cancer
Cancer Res., December 1, 2000; 60(23): 6623 - 6629.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
A. K. Sarkar and J. G. Nuchtern
Lysis of MYCN-amplified Neuroblastoma Cells by MYCN Peptide-specific Cytotoxic T Lymphocytes
Cancer Res., April 1, 2000; 60(7): 1908 - 1913.
[Abstract] [Full Text]


Home page
J Biol ChemHome page
K. Noguchi, C. Kitanaka, H. Yamana, A. Kokubu, T. Mochizuki, and Y. Kuchino
Regulation of c-Myc through Phosphorylation at Ser-62 and Ser-71 by c-Jun N-Terminal Kinase
J. Biol. Chem., November 12, 1999; 274(46): 32580 - 32587.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1998 by the American Association of Cancer Research.